CombinatoRx and Fovea in Alliance to Treat Ophthalmic Disease
Business Review Editor
Abstract
CombinatoRx and Fovea Pharmaceuticals entered into a collaboration agreement to develop and potentially commercialize combination drugs to treat ophthalmic diseases.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.